Published in J Clin Microbiol on April 01, 1985
Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J Clin Microbiol (2005) 1.61
Effective and reduced-cost modified selective medium for isolation of Clostridium difficile. J Clin Microbiol (2008) 1.48
Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients. Infect Immun (1991) 1.17
Identification of Clostridium difficile in stool specimens by culture-enhanced gas-liquid chromatography. J Clin Microbiol (1989) 1.03
Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples. J Clin Microbiol (2013) 0.85
Recovery of Clostridium difficile from hospital environments. J Clin Microbiol (2006) 0.85
Comparison of ChromID agar and Clostridium difficile selective agar for effective isolation of C. difficile from stool specimens. Ann Lab Med (2013) 0.81
Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol (2016) 0.75
Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol (1979) 12.54
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol (1982) 4.35
Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis (1981) 3.76
Antibiotic-associated pseudomembranous colitis. Rev Infect Dis (1980) 3.02
Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol (1983) 2.15
Studies on the epidemiology of colitis due to Clostridium difficile in hamsters. J Infect Dis (1981) 1.24
Comparison of methods for recovery of Clostridium difficile from an environmental surface. J Clin Microbiol (1983) 1.16
Epidemiology of colitis induced by Clostridium difficile in hamsters: application of a bacteriophage and bacteriocin typing system. J Infect Dis (1984) 1.11
Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 6.79
Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis (1981) 3.76
Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol (1997) 3.70
A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA (1994) 3.66
Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis (1980) 2.59
Clindamycin-induced enterocolitis in hamsters. J Infect Dis (1978) 2.43
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol (1999) 2.40
Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med (1981) 2.08
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis (2000) 2.06
Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1987) 1.93
Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology (1979) 1.80
Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis. Am J Clin Nutr (1980) 1.73
The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis. J Antimicrob Chemother (1987) 1.69
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Intraleukocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Am J Med (1984) 1.64
Bacteremia caused by Achromobacter species in an immunocompromised host. J Clin Microbiol (1984) 1.62
Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis (1992) 1.58
Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis (1982) 1.53
Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med (1982) 1.51
Evaluation of new anti-infective drugs for the treatment of gastritis and peptic ulcer disease associated with infection by Helicobacter pylori. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.44
The protective effect of vancomycin on clindamycin-induced colitis in hamsters. Johns Hopkins Med J (1977) 1.42
Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis. Gut (1980) 1.37
Evaluation of eight cephalosporins in hamster colitis model. Antimicrob Agents Chemother (1981) 1.35
Vancomycin. Med Clin North Am (1982) 1.32
Gastrointestinal and systemic toxicity of fecal extracts from hamsters with clindamycin-induced colitis. Gastroenterology (1978) 1.29
Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med (1996) 1.25
Studies on the epidemiology of colitis due to Clostridium difficile in hamsters. J Infect Dis (1981) 1.24
Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol (1987) 1.23
Comparison of methods for recovery of Clostridium difficile from an environmental surface. J Clin Microbiol (1983) 1.16
Treatment of antibiotic-associated colitis with vancomycin. J Antimicrob Chemother (1984) 1.15
Relapsing pseudomembranous colitis associated with cancer chemotherapy. J Infect Dis (1981) 1.15
Treatment of Clostridium difficile colitis and diarrhea with vancomycin. Am J Med (1981) 1.14
Epidemiology of colitis induced by Clostridium difficile in hamsters: application of a bacteriophage and bacteriocin typing system. J Infect Dis (1984) 1.11
Hospital-acquired infective endocarditis. Arch Intern Med (1988) 1.09
Ampicillin-induced enterocolitis: implication of toxigenic Clostridium perfringens type C. J Pediatr (1980) 1.07
Clindamycin-induced colitis. Am J Clin Nutr (1979) 1.07
Cell-mediated immunity in diabetes mellitus. Infect Immun (1978) 1.06
Clostridia and antimicrobial enterocolitis. Annu Rev Med (1981) 1.04
Bordetella bronchiseptica pneumonia in a patient with chronic lymphocytic leukemia. South Med J (1987) 1.03
Recent advances in management of bacterial diarrhea. Rev Infect Dis (1983) 1.02
Inciting and etiologic agents of colitis. Rev Infect Dis (1984) 0.99
Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea. Diagn Microbiol Infect Dis (1994) 0.96
Epidemiology of Clostridium difficile colonization in newborns: results using a bacteriophage and bacteriocin typing system. J Infect Dis (1988) 0.95
Cerebrospinal fluid lymphocyte transformations in meningitis. Arch Intern Med (1979) 0.95
Etiology of tetracycline-associated pseudomembranous colitis in hamsters. Antimicrob Agents Chemother (1979) 0.95
Persistent staphylococcal bacteremia in an intravenous drug abuser. Antimicrob Agents Chemother (1986) 0.94
Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits. Antimicrob Agents Chemother (1987) 0.92
Lethal pancreatitis. Am J Gastroenterol (1983) 0.91
Infective endocarditis: clinical features in young and elderly patients. Am J Med (1987) 0.89
Evaluation of new anti-infective drugs for the treatment of acute infectious diarrhea. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.86
Office treatment of infection. 1. Respiratory infections. Postgrad Med (1980) 0.86
Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient. Am J Med (1997) 0.85
In vitro synergy studies with Clostridium difficile. Antimicrob Agents Chemother (1991) 0.84
Rifampicin and antibiotic-associated colitis. Lancet (1981) 0.83
Clostridium difficile plasmid isolation as an epidemiologic tool. Eur J Clin Microbiol Infect Dis (1988) 0.82
Cell-mediated immune responses in sporotrichosis. J Infect Dis (1979) 0.82
Paid time off for blood donation--an incentive to be less than truthful? Transfusion (1997) 0.81
Mycobacterium avium complex-induced septic arthritis and osteomyelitis in a patient with the acquired immunodeficiency syndrome. Arthritis Rheum (1990) 0.81
The management of the carrier of methicillin-resistant Staphylococcus aureus. Curr Clin Top Infect Dis (1987) 0.81
Treatment of antibiotic-associated enterocolitis with vancomycin. Rev Infect Dis (1982) 0.80
Factors affecting survival in prosthetic valve endocarditis. Review of the effectiveness of prophylaxis. Chest (1984) 0.80
Clostridium difficile colitis: causes, cures. JAMA (1993) 0.79
Antibiotic-associated colitis due to Clostridium difficile in a Kodiak bear. Am J Vet Res (1983) 0.79
Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus. J Clin Endocrinol Metab (1994) 0.79
Serial bilirubin determinations as a prognostic marker in clinical infections. Am J Med Sci (1989) 0.79
Effect of therapy with latamoxef (moxalactam) on carriage of Clostridium difficile. J Antimicrob Chemother (1984) 0.79
Nocardia asteroides meningitis without brain abscess. Rev Infect Dis (1987) 0.79
Evaluation of new anti-infective drugs for the treatment of typhoid fever. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.78
Abnormal lymphocyte responses in residents of a town with a cluster of Hodgkin's disease. Clin Exp Immunol (1979) 0.78
Effects of topical clindamycin on intestinal microflora in patients with acne. J Am Acad Dermatol (1986) 0.76
Rifampin and pseudomembranous colitis. Rev Infect Dis (1983) 0.76
Thyroid hormones and the acquired immunodeficiency syndrome (AIDS) Ann Intern Med (1989) 0.75
Pneumocystis carinii pneumonia complicating intermittent Cushing's syndrome. Wis Med J (1986) 0.75
Prevention and treatment of viral infections: problems and current recommendations. Postgrad Med (1981) 0.75
Quantitative nitro blue tetrazolium test in febrile patients. Correlation with diagnosis and bacterial activity of leukocytes. Arch Intern Med (1975) 0.75
In-vitro activity of Sch 34343 against nosocomial pathogens: methicillin-resistant staphylococci, gentamicin-susceptible and -resistant Streptococcus faecalis, Clostridium difficile and Bacteroides fragilis. J Antimicrob Chemother (1985) 0.75
Pharmacokinetic and pharmacodynamic comparison of mezlocillin and ticarcillin. Clin Pharm (1988) 0.75
Office treatment of infection. 2. Nonrespiratory bacterial infections, antibiotic prophylaxis, fungal and viral infections. Postgrad Med (1980) 0.75
Evaluation of new anti-infective drugs for the treatment of cholera. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.75
Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Cryptosporidium. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.75
Suppression of immune response in mice by navy bean lectin. J Clin Lab Immunol (1980) 0.75
Evaluation of new anti-infective drugs for the treatment of chronic carriage of Salmonella. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.75
Diagnosis of perirectal Pneumocystis carinii infection by direct immunofluorescence. Clin Infect Dis (1993) 0.75
Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Giardia lamblia. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.75
Combined leukocyte and bone imaging used to evaluate diabetic osteoarthropathy and osteomyelitis. Clin Nucl Med (1989) 0.75
Cavitary lung nodule caused by Hemophilus influenzae. Wis Med J (1987) 0.75
Evaluation of new anti-infective drugs for the treatment of diarrhea caused by Entamoeba histolytica. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 0.75
MR findings in an AIDS patient with cytomegalovirus retinitis. AJR Am J Roentgenol (1992) 0.75